Symbiomics
PrivateLast Round
Grant
Oct 23, 2025
Total Funding Raised
$2.84M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Symbiomics operates in Healthcare & Life Sciences and is based in Florianópolis. Its latest recorded funding round was a Grant round in October 2025.
Symbiomics is a biotechnology company that develops high-performance biological products for agriculture to enhance crop productivity and sustainability.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symbiomics Comparables
Compare Symbiomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nunatak Biotech | 84% | |
| Puna Bio | 79% | |
| Gênica Inovação Biotecnológica | 77% |
For institutional investors. Book with your work email.
Symbiomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 23, 2025 | ||||
| Series A | Jun 25, 2025 | ||||
| Seed | Dec 14, 2023 | ||||
| Seed | Jan 27, 2023 | ||||
| Pre Seed | Feb 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Symbiomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baraúna Investimentos | Seed |
| MOV Investimentos | Seed, Series A |
| Arar Capital | Seed, Series A |
| Vesper | Seed, Pre Seed |
| Ecoa Capital | Seed |
| The Yield Lab Latam | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 21, 4.5x the trailing average.
- Jul 13, 2026
Open roles increased to 10, representing 32% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 23, 2026
Symbiomics and Valeouro Biotec announce a strategic partnership to develop a new generation of disease-management solutions for Brazil’s main agricultural systems, combining Symbiomics’s microorganism discovery and genome-editing platform with Valeouro’s agricultural, market-access, technical and industrial expertise, with market delivery expected within two to three years.
- partners_withSep 23, 2026
Symbiomics and Valeouro Biotec announce a strategic partnership in Brazil on Sep 23rd '26 to develop a new generation of disease-management solutions, combining Symbiomics's microorganism discovery and genome-editing platform with Valeouro Biotec's Brazilian agriculture expertise and market-access, technical and industrial capabilities; the solutions are expected to reach the market within two to three years.
For institutional investors. Book with your work email.
Symbiomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Symbiomics's valuation, stock price, and market status.
Is Symbiomics a public or private company?
Symbiomics is a private company.
What is the current stock price of Symbiomics?
Symbiomics is a private company, so its shares have no public market price. Caplight tracks Symbiomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Symbiomics worth (valuation)?
Valuation information for Symbiomics is not publicly available.
Can I buy Symbiomics stock?
Symbiomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Symbiomics's last funding round?
Symbiomics's most recent funding round was Grant on October 23, 2025.
Who are the main investors in Symbiomics?
Key investors in Symbiomics include Baraúna Investimentos, MOV Investimentos, Arar Capital, Vesper, Ecoa Capital.
Will Symbiomics IPO soon?
No public IPO plans have been announced for Symbiomics.
How can I track Symbiomics secondary market activity?
Caplight tracks bids, offers, and trades in Symbiomics's shares on secondary markets.